AlzeCure gets Abstract Accepted on New Potential Disease-Modifying Effects of ACD856 Against Alzheimer's

STOCKHOLM, SWEDEN / ACCESSWIRE / December 20, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting …